2.70300 EUR
0.036
1.31%
Last update Dec 16, 7:37 PM CET
Market closed
Day range
2.68200
2.79200
Previous close
2.73900
Open
2.72300
Access this stock data via API
Subscribe
Aclaris Therapeutics Inc.
2.70
0.04
1.31%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 2.8M 1.5M 1.2M 7.9M
Cost of revenue 2.1M 1.6M 1.3M 7.9M
Gross profit 724.4K -62.2K -52.0K -76.7K
Operating expense
Research & development 11.1M 9.8M 9.9M 7.7M
Selling general and admin 4.2M 4.6M 5.2M 4.2M
Other operating expenses
Operating income -14.5M -14.4M -15.2M -12.0M
Non operating interest income
Income 1.6M 1.7M 1.8M
Expense
Other income expense 525.0K -459.4K 454.2K -65.3M
Pretax income -12.5M -13.1M -12.9M -82.3M
Tax provision
Net income -12.5M -13.1M -12.9M -82.3M
Basic EPS -0.1 -0.1 -0.1 -1.0
Diluted EPS -0.1 -0.1 -0.1 -1.0
Basic average shares 104.5M 104.5M 104.3M 81.2M
Diluted average shares 104.5M 104.5M 104.3M 81.2M
EBITDA -14.4M -13.0M -14.8M 61.1M
Net income from continuing op. -12.5M -13.1M -12.9M -82.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 2 minutes

07:57
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).